المؤلفون: Masmiquel, L, Leiter, LA, Vidal, J, Bain, S, Petrie, J, Franek, E, Raz, I, Comlekci, A, Jacob, S, van Gaal, L, Baeres, FMM, Marso, SP, Eriksson, M

المصدر: Cardiovascular diabetology. 15:29

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:132941271

المؤلفون: J. Vidal, Rutten Gehm, Baeres Fmm, Martin Haluzik, Edward Franek, Mota M, Stephan Jacob, David D. Ørsted, Stephen C. Bain

المصدر: Journal of Diabetes & Metabolism.

مصطلحات موضوعية: medicine.medical_specialty, business.industry, Liraglutide, 030209 endocrinology & metabolism, Type 2 diabetes, 030204 cardiovascular system & hematology, medicine.disease, Metformin, Eastern european, 03 medical and health sciences, 0302 clinical medicine, Blood pressure, Diabetes mellitus, Internal medicine, medicine, media_common.cataloged_instance, Mass index, European union, business, media_common, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35efd068fbb1cc6faadc0c1e5c8beaa5
https://doi.org/10.4172/2155-6156.1000646

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Perkovic V; From the University of New South Wales, Sydney (V.P.); the Division of Nephrology, University of Washington School of Medicine, Seattle, and Providence Medical Research Center, Providence Inland Northwest Health, Spokane - both in Washington (K.R.T.); Steno Diabetes Center Copenhagen, Herlev (P.R.), the Department of Clinical Medicine, University of Copenhagen, Copenhagen (P.R.), and Novo Nordisk, Søborg (F.M.M.B., T.I., H.B.-T., N.L.L.) - all in Denmark; Stanford Center for Clinical Research, Department of Medicine, Stanford School of Medicine, Palo Alto, CA (K.W.M.); KfH Kidney Center, Munich, and University Hospital, Friedrich-Alexander University, Erlangen - both in Germany (J.F.E.M.); the Department of Medicine, American Heart Association Comprehensive Hypertension Center, University of Chicago Medicine, Chicago (G.B.); and AdventHealth Translational Research Institute, Orlando, FL (R.P.)., Tuttle KR; From the University of New South Wales, Sydney (V.P.); the Division of Nephrology, University of Washington School of Medicine, Seattle, and Providence Medical Research Center, Providence Inland Northwest Health, Spokane - both in Washington (K.R.T.); Steno Diabetes Center Copenhagen, Herlev (P.R.), the Department of Clinical Medicine, University of Copenhagen, Copenhagen (P.R.), and Novo Nordisk, Søborg (F.M.M.B., T.I., H.B.-T., N.L.L.) - all in Denmark; Stanford Center for Clinical Research, Department of Medicine, Stanford School of Medicine, Palo Alto, CA (K.W.M.); KfH Kidney Center, Munich, and University Hospital, Friedrich-Alexander University, Erlangen - both in Germany (J.F.E.M.); the Department of Medicine, American Heart Association Comprehensive Hypertension Center, University of Chicago Medicine, Chicago (G.B.); and AdventHealth Translational Research Institute, Orlando, FL (R.P.)., Rossing P; From the University of New South Wales, Sydney (V.P.); the Division of Nephrology, University of Washington School of Medicine, Seattle, and Providence Medical Research Center, Providence Inland Northwest Health, Spokane - both in Washington (K.R.T.); Steno Diabetes Center Copenhagen, Herlev (P.R.), the Department of Clinical Medicine, University of Copenhagen, Copenhagen (P.R.), and Novo Nordisk, Søborg (F.M.M.B., T.I., H.B.-T., N.L.L.) - all in Denmark; Stanford Center for Clinical Research, Department of Medicine, Stanford School of Medicine, Palo Alto, CA (K.W.M.); KfH Kidney Center, Munich, and University Hospital, Friedrich-Alexander University, Erlangen - both in Germany (J.F.E.M.); the Department of Medicine, American Heart Association Comprehensive Hypertension Center, University of Chicago Medicine, Chicago (G.B.); and AdventHealth Translational Research Institute, Orlando, FL (R.P.)., Mahaffey KW; From the University of New South Wales, Sydney (V.P.); the Division of Nephrology, University of Washington School of Medicine, Seattle, and Providence Medical Research Center, Providence Inland Northwest Health, Spokane - both in Washington (K.R.T.); Steno Diabetes Center Copenhagen, Herlev (P.R.), the Department of Clinical Medicine, University of Copenhagen, Copenhagen (P.R.), and Novo Nordisk, Søborg (F.M.M.B., T.I., H.B.-T., N.L.L.) - all in Denmark; Stanford Center for Clinical Research, Department of Medicine, Stanford School of Medicine, Palo Alto, CA (K.W.M.); KfH Kidney Center, Munich, and University Hospital, Friedrich-Alexander University, Erlangen - both in Germany (J.F.E.M.); the Department of Medicine, American Heart Association Comprehensive Hypertension Center, University of Chicago Medicine, Chicago (G.B.); and AdventHealth Translational Research Institute, Orlando, FL (R.P.)., Mann JFE; From the University of New South Wales, Sydney (V.P.); the Division of Nephrology, University of Washington School of Medicine, Seattle, and Providence Medical Research Center, Providence Inland Northwest Health, Spokane - both in Washington (K.R.T.); Steno Diabetes Center Copenhagen, Herlev (P.R.), the Department of Clinical Medicine, University of Copenhagen, Copenhagen (P.R.), and Novo Nordisk, Søborg (F.M.M.B., T.I., H.B.-T., N.L.L.) - all in Denmark; Stanford Center for Clinical Research, Department of Medicine, Stanford School of Medicine, Palo Alto, CA (K.W.M.); KfH Kidney Center, Munich, and University Hospital, Friedrich-Alexander University, Erlangen - both in Germany (J.F.E.M.); the Department of Medicine, American Heart Association Comprehensive Hypertension Center, University of Chicago Medicine, Chicago (G.B.); and AdventHealth Translational Research Institute, Orlando, FL (R.P.)., Bakris G; From the University of New South Wales, Sydney (V.P.); the Division of Nephrology, University of Washington School of Medicine, Seattle, and Providence Medical Research Center, Providence Inland Northwest Health, Spokane - both in Washington (K.R.T.); Steno Diabetes Center Copenhagen, Herlev (P.R.), the Department of Clinical Medicine, University of Copenhagen, Copenhagen (P.R.), and Novo Nordisk, Søborg (F.M.M.B., T.I., H.B.-T., N.L.L.) - all in Denmark; Stanford Center for Clinical Research, Department of Medicine, Stanford School of Medicine, Palo Alto, CA (K.W.M.); KfH Kidney Center, Munich, and University Hospital, Friedrich-Alexander University, Erlangen - both in Germany (J.F.E.M.); the Department of Medicine, American Heart Association Comprehensive Hypertension Center, University of Chicago Medicine, Chicago (G.B.); and AdventHealth Translational Research Institute, Orlando, FL (R.P.)., Baeres FMM; From the University of New South Wales, Sydney (V.P.); the Division of Nephrology, University of Washington School of Medicine, Seattle, and Providence Medical Research Center, Providence Inland Northwest Health, Spokane - both in Washington (K.R.T.); Steno Diabetes Center Copenhagen, Herlev (P.R.), the Department of Clinical Medicine, University of Copenhagen, Copenhagen (P.R.), and Novo Nordisk, Søborg (F.M.M.B., T.I., H.B.-T., N.L.L.) - all in Denmark; Stanford Center for Clinical Research, Department of Medicine, Stanford School of Medicine, Palo Alto, CA (K.W.M.); KfH Kidney Center, Munich, and University Hospital, Friedrich-Alexander University, Erlangen - both in Germany (J.F.E.M.); the Department of Medicine, American Heart Association Comprehensive Hypertension Center, University of Chicago Medicine, Chicago (G.B.); and AdventHealth Translational Research Institute, Orlando, FL (R.P.)., Idorn T; From the University of New South Wales, Sydney (V.P.); the Division of Nephrology, University of Washington School of Medicine, Seattle, and Providence Medical Research Center, Providence Inland Northwest Health, Spokane - both in Washington (K.R.T.); Steno Diabetes Center Copenhagen, Herlev (P.R.), the Department of Clinical Medicine, University of Copenhagen, Copenhagen (P.R.), and Novo Nordisk, Søborg (F.M.M.B., T.I., H.B.-T., N.L.L.) - all in Denmark; Stanford Center for Clinical Research, Department of Medicine, Stanford School of Medicine, Palo Alto, CA (K.W.M.); KfH Kidney Center, Munich, and University Hospital, Friedrich-Alexander University, Erlangen - both in Germany (J.F.E.M.); the Department of Medicine, American Heart Association Comprehensive Hypertension Center, University of Chicago Medicine, Chicago (G.B.); and AdventHealth Translational Research Institute, Orlando, FL (R.P.)., Bosch-Traberg H; From the University of New South Wales, Sydney (V.P.); the Division of Nephrology, University of Washington School of Medicine, Seattle, and Providence Medical Research Center, Providence Inland Northwest Health, Spokane - both in Washington (K.R.T.); Steno Diabetes Center Copenhagen, Herlev (P.R.), the Department of Clinical Medicine, University of Copenhagen, Copenhagen (P.R.), and Novo Nordisk, Søborg (F.M.M.B., T.I., H.B.-T., N.L.L.) - all in Denmark; Stanford Center for Clinical Research, Department of Medicine, Stanford School of Medicine, Palo Alto, CA (K.W.M.); KfH Kidney Center, Munich, and University Hospital, Friedrich-Alexander University, Erlangen - both in Germany (J.F.E.M.); the Department of Medicine, American Heart Association Comprehensive Hypertension Center, University of Chicago Medicine, Chicago (G.B.); and AdventHealth Translational Research Institute, Orlando, FL (R.P.)., Lausvig NL; From the University of New South Wales, Sydney (V.P.); the Division of Nephrology, University of Washington School of Medicine, Seattle, and Providence Medical Research Center, Providence Inland Northwest Health, Spokane - both in Washington (K.R.T.); Steno Diabetes Center Copenhagen, Herlev (P.R.), the Department of Clinical Medicine, University of Copenhagen, Copenhagen (P.R.), and Novo Nordisk, Søborg (F.M.M.B., T.I., H.B.-T., N.L.L.) - all in Denmark; Stanford Center for Clinical Research, Department of Medicine, Stanford School of Medicine, Palo Alto, CA (K.W.M.); KfH Kidney Center, Munich, and University Hospital, Friedrich-Alexander University, Erlangen - both in Germany (J.F.E.M.); the Department of Medicine, American Heart Association Comprehensive Hypertension Center, University of Chicago Medicine, Chicago (G.B.); and AdventHealth Translational Research Institute, Orlando, FL (R.P.)., Pratley R; From the University of New South Wales, Sydney (V.P.); the Division of Nephrology, University of Washington School of Medicine, Seattle, and Providence Medical Research Center, Providence Inland Northwest Health, Spokane - both in Washington (K.R.T.); Steno Diabetes Center Copenhagen, Herlev (P.R.), the Department of Clinical Medicine, University of Copenhagen, Copenhagen (P.R.), and Novo Nordisk, Søborg (F.M.M.B., T.I., H.B.-T., N.L.L.) - all in Denmark; Stanford Center for Clinical Research, Department of Medicine, Stanford School of Medicine, Palo Alto, CA (K.W.M.); KfH Kidney Center, Munich, and University Hospital, Friedrich-Alexander University, Erlangen - both in Germany (J.F.E.M.); the Department of Medicine, American Heart Association Comprehensive Hypertension Center, University of Chicago Medicine, Chicago (G.B.); and AdventHealth Translational Research Institute, Orlando, FL (R.P.).

مؤلفون مشاركون: FLOW Trial Committees and Investigators

المصدر: The New England journal of medicine [N Engl J Med] 2024 Jul 11; Vol. 391 (2), pp. 109-121. Date of Electronic Publication: 2024 May 24.

نوع المنشور: Journal Article; Randomized Controlled Trial; Multicenter Study

بيانات الدورية: Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE

مواضيع طبية MeSH: Glucagon-Like Peptides*/therapeutic use , Glucagon-Like Peptides*/adverse effects , Diabetes Mellitus, Type 2*/complications , Diabetes Mellitus, Type 2*/drug therapy , Renal Insufficiency, Chronic*/complications , Renal Insufficiency, Chronic*/mortality , Glomerular Filtration Rate*/drug effects , Hypoglycemic Agents*/therapeutic use , Hypoglycemic Agents*/adverse effects , Cardiovascular Diseases*/prevention & control , Cardiovascular Diseases*/mortality , Cardiovascular Diseases*/etiology, Humans ; Male ; Female ; Middle Aged ; Aged ; Double-Blind Method ; Diabetic Nephropathies/mortality ; Injections, Subcutaneous

المؤلفون: Rossing P; Complication Research, Steno Diabetes Center Copenhagen, Herlev, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Baeres FMM; Novo Nordisk A/S, Søborg, Denmark., Bakris G; Department of Medicine, AHA Comprehensive Hypertension Center, University of Chicago Medicine, Chicago, IL, USA., Bosch-Traberg H; Novo Nordisk A/S, Søborg, Denmark., Gislum M; Novo Nordisk A/S, Søborg, Denmark., Gough SCL; Novo Nordisk A/S, Søborg, Denmark., Idorn T; Novo Nordisk A/S, Søborg, Denmark., Lawson J; Novo Nordisk A/S, Søborg, Denmark., Mahaffey KW; Department of Medicine, Stanford Center for Clinical Research, Stanford School of Medicine, Palo Alto, CA, USA., Mann JFE; Outpatients Clinic, KfH Kidney Center, München, Germany., Mersebach H; Novo Nordisk A/S, Søborg, Denmark., Perkovic V; Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia., Tuttle K; Division of Nephrology, University of Washington/Providence Health Care, Spokane, WA, USA., Pratley R; Translational Research Institute, AdventHealth, Orlando, FL, USA.

المصدر: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association [Nephrol Dial Transplant] 2023 Aug 31; Vol. 38 (9), pp. 2041-2051.

نوع المنشور: Randomized Controlled Trial; Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 8706402 Publication Model: Print Cited Medium: Internet ISSN: 1460-2385 (Electronic) Linking ISSN: 09310509 NLM ISO Abbreviation: Nephrol Dial Transplant Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Mellitus, Type 2*/complications , Diabetes Mellitus, Type 2*/drug therapy , Diabetes Mellitus, Type 2*/urine , Renal Insufficiency, Chronic*/complications , Renal Insufficiency, Chronic*/drug therapy, Humans ; Aged ; Kidney ; Glucagon-Like Peptides/therapeutic use ; Glucagon-Like Peptides/pharmacology ; Hypoglycemic Agents/therapeutic use ; Hypoglycemic Agents/pharmacology

المؤلفون: Ridker PM; Center for Cardiovascular Disease Prevention, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; the Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: pridker@bwh.harvard.edu., Devalaraja M; Corvidia Therapeutics, Waltham, MA, USA., Baeres FMM; Novo Nordisk, Bagsvaerd, Denmark., Engelmann MDM; Novo Nordisk, Bagsvaerd, Denmark., Hovingh GK; Novo Nordisk, Bagsvaerd, Denmark., Ivkovic M; Novo Nordisk, Bagsvaerd, Denmark., Lo L; Corvidia Therapeutics, Waltham, MA, USA., Kling D; Corvidia Therapeutics, Waltham, MA, USA., Pergola P; Renal Associates, San Antonio, TX, USA., Raj D; Division of Kidney Diseases and Hypertension, George Washington University, Washington, DC, USA., Libby P; the Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Davidson M; Corvidia Therapeutics, Waltham, MA, USA.

مؤلفون مشاركون: RESCUE Investigators

المصدر: Lancet (London, England) [Lancet] 2021 May 29; Vol. 397 (10289), pp. 2060-2069. Date of Electronic Publication: 2021 May 17.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal, Humanized/*administration & dosage , C-Reactive Protein/*drug effects , Interleukin-6/*antagonists & inhibitors , Renal Insufficiency, Chronic/*drug therapy, Aged ; Atherosclerosis ; Biomarkers/blood ; Double-Blind Method ; Female ; Humans ; Inflammation/complications ; Inflammation/drug therapy ; Injections, Subcutaneous ; Male ; Middle Aged ; Renal Insufficiency, Chronic/complications ; Thrombosis/complications ; Treatment Outcome

المؤلفون: Weng W; Novo Nordisk Inc., Plainsboro, NJ, USA. Electronic address: wayw@novonordisk.com., Liang Y; Novo Nordisk Inc., Plainsboro, NJ, USA., Brett J; Novo Nordisk Inc., Plainsboro, NJ, USA., Hobbs T; Novo Nordisk Inc., Plainsboro, NJ, USA., Baeres FMM; Novo Nordisk A/S, Søborg, Denmark.

المصدر: Journal of diabetes and its complications [J Diabetes Complications] 2020 May; Vol. 34 (5), pp. 107500. Date of Electronic Publication: 2019 Dec 02.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Science Pub. Co Country of Publication: United States NLM ID: 9204583 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-460X (Electronic) Linking ISSN: 10568727 NLM ISO Abbreviation: J Diabetes Complications Subsets: MEDLINE

مواضيع طبية MeSH: Atherosclerosis/*epidemiology , Diabetes Mellitus, Type 2/*epidemiology, Adolescent ; Adult ; Age Factors ; Aged ; Atherosclerosis/economics ; Cardiovascular Diseases/economics ; Cardiovascular Diseases/epidemiology ; Databases, Factual ; Diabetes Mellitus, Type 2/diagnosis ; Diabetes Mellitus, Type 2/economics ; Female ; Health Care Costs/statistics & numerical data ; Humans ; Longitudinal Studies ; Male ; Middle Aged ; Patient Acceptance of Health Care/statistics & numerical data ; Propensity Score ; Retrospective Studies ; Risk ; United States/epidemiology ; Young Adult